These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


472 related items for PubMed ID: 30293230

  • 1. A combination of hydroxytyrosol, omega-3 fatty acids and curcumin improves pain and inflammation among early stage breast cancer patients receiving adjuvant hormonal therapy: results of a pilot study.
    Martínez N, Herrera M, Frías L, Provencio M, Pérez-Carrión R, Díaz V, Morse M, Crespo MC.
    Clin Transl Oncol; 2019 Apr; 21(4):489-498. PubMed ID: 30293230
    [Abstract] [Full Text] [Related]

  • 2. Randomized Multicenter Placebo-Controlled Trial of Omega-3 Fatty Acids for the Control of Aromatase Inhibitor-Induced Musculoskeletal Pain: SWOG S0927.
    Hershman DL, Unger JM, Crew KD, Awad D, Dakhil SR, Gralow J, Greenlee H, Lew DL, Minasian LM, Till C, Wade JL, Meyskens FL, Moinpour CM.
    J Clin Oncol; 2015 Jun 10; 33(17):1910-7. PubMed ID: 25940724
    [Abstract] [Full Text] [Related]

  • 3. Randomized placebo-controlled pilot trial of omega 3 fatty acids for prevention of aromatase inhibitor-induced musculoskeletal pain.
    Lustberg MB, Orchard TS, Reinbolt R, Andridge R, Pan X, Belury M, Cole R, Logan A, Layman R, Ramaswamy B, Wesolowski R, Berger M, Patterson E, Loprinzi C, Shapiro CL, Yee L.
    Breast Cancer Res Treat; 2018 Feb 10; 167(3):709-718. PubMed ID: 29101597
    [Abstract] [Full Text] [Related]

  • 4. Effect of Aromatase Inhibitor Therapy on Sleep and Activity Patterns in Early-stage Breast Cancer.
    Bhave MA, Speth KA, Kidwell KM, Lyden A, Alsamarraie C, Murphy SL, Henry NL.
    Clin Breast Cancer; 2018 Apr 10; 18(2):168-174.e2. PubMed ID: 29361424
    [Abstract] [Full Text] [Related]

  • 5. A prospective study of aromatase inhibitor therapy, vitamin D, C-reactive protein and musculoskeletal symptoms.
    Helzlsouer KJ, Gallicchio L, MacDonald R, Wood B, Rushovich E.
    Breast Cancer Res Treat; 2012 Jan 10; 131(1):277-85. PubMed ID: 21904883
    [Abstract] [Full Text] [Related]

  • 6. Pilot study of acupuncture for the treatment of joint symptoms related to adjuvant aromatase inhibitor therapy in postmenopausal breast cancer patients.
    Crew KD, Capodice JL, Greenlee H, Apollo A, Jacobson JS, Raptis G, Blozie K, Sierra A, Hershman DL.
    J Cancer Surviv; 2007 Dec 10; 1(4):283-91. PubMed ID: 18648963
    [Abstract] [Full Text] [Related]

  • 7. A prospective assessment of musculoskeletal toxicity and loss of grip strength in breast cancer patients receiving adjuvant aromatase inhibitors and tamoxifen, and relation with BMI.
    Lintermans A, Van Asten K, Wildiers H, Laenen A, Paridaens R, Weltens C, Verhaeghe J, Vanderschueren D, Smeets A, Van Limbergen E, Leunen K, Christiaens MR, Neven P.
    Breast Cancer Res Treat; 2014 Jul 10; 146(1):109-16. PubMed ID: 24816806
    [Abstract] [Full Text] [Related]

  • 8. Randomized trial of vitamin D3 to prevent worsening of musculoskeletal symptoms in women with breast cancer receiving adjuvant letrozole. The VITAL trial.
    Khan QJ, Kimler BF, Reddy PS, Sharma P, Klemp JR, Nydegger JL, Yeh HW, Fabian CJ.
    Breast Cancer Res Treat; 2017 Nov 10; 166(2):491-500. PubMed ID: 28770449
    [Abstract] [Full Text] [Related]

  • 9. Predictors of Pain Reduction in Trials of Interventions for Aromatase Inhibitor-Associated Musculoskeletal Symptoms.
    Henry NL, Unger JM, Till C, Crew KD, Fisch MJ, Hershman DL.
    JNCI Cancer Spectr; 2021 Dec 10; 5(6):. PubMed ID: 34901744
    [Abstract] [Full Text] [Related]

  • 10. Omega-3 fatty acid use for obese breast cancer patients with aromatase inhibitor-related arthralgia (SWOG S0927).
    Shen S, Unger JM, Crew KD, Till C, Greenlee H, Gralow J, Dakhil SR, Minasian LM, Wade JL, Fisch MJ, Henry NL, Hershman DL.
    Breast Cancer Res Treat; 2018 Dec 10; 172(3):603-610. PubMed ID: 30159789
    [Abstract] [Full Text] [Related]

  • 11. Effects of the Chinese medicine Yi Shen Jian Gu granules on aromatase inhibitor-associated musculoskeletal symptoms: A randomized, controlled clinical trial.
    Peng N, Yu M, Yang G, Fu Q, Xu Y, Yu J, Liu Q, Li C, Xu W, Zhang Y, Ma C, Yang L, Yu R, Wang X.
    Breast; 2018 Feb 10; 37():18-27. PubMed ID: 29059538
    [Abstract] [Full Text] [Related]

  • 12. A dual-center randomized controlled double blind trial assessing the effect of acupuncture in reducing musculoskeletal symptoms in breast cancer patients taking aromatase inhibitors.
    Bao T, Cai L, Giles JT, Gould J, Tarpinian K, Betts K, Medeiros M, Jeter S, Tait N, Chumsri S, Armstrong DK, Tan M, Folkerd E, Dowsett M, Singh H, Tkaczuk K, Stearns V.
    Breast Cancer Res Treat; 2013 Feb 10; 138(1):167-74. PubMed ID: 23393007
    [Abstract] [Full Text] [Related]

  • 13. Genetic variant in the osteoprotegerin gene is associated with aromatase inhibitor-related musculoskeletal toxicity in breast cancer patients.
    Lintermans A, Van Asten K, Jongen L, Van Brussel T, Laenen A, Verhaeghe J, Vanderschueren D, Lambrechts D, Neven P.
    Eur J Cancer; 2016 Mar 10; 56():31-36. PubMed ID: 26798969
    [Abstract] [Full Text] [Related]

  • 14. A Novel Combination of ω-3 Fatty Acids and Nano-Curcumin Modulates Interleukin-6 Gene Expression and High Sensitivity C-reactive Protein Serum Levels in Patients with Migraine: A Randomized Clinical Trial Study.
    Abdolahi M, Sarraf P, Javanbakht MH, Honarvar NM, Hatami M, Soveyd N, Tafakhori A, Sedighiyan M, Djalali M, Jafarieh A, Masoudian Y, Djalali M.
    CNS Neurol Disord Drug Targets; 2018 Mar 10; 17(6):430-438. PubMed ID: 29938621
    [Abstract] [Full Text] [Related]

  • 15. Complementary and alternative medicine and musculoskeletal pain in the first year of adjuvant aromatase inhibitor treatment in early breast cancer patients.
    Hack CC, Häberle L, Brucker SY, Janni W, Volz B, Loehberg CR, Hartkopf AD, Walter CB, Baake G, Fridman A, Malter W, Wuerstlein R, Harbeck N, Hoffmann O, Kuemmel S, Martin B, Thomssen C, Graf H, Wolf C, Lux MP, Bayer CM, Rauh C, Almstedt K, Gass P, Heindl F, Brodkorb T, Willer L, Lindner C, Kolberg HC, Krabisch P, Weigel M, Steinfeld-Birg D, Kohls A, Brucker C, Schulz V, Fischer G, Pelzer V, Rack B, Beckmann MW, Fehm T, Rody A, Maass N, Hein A, Fasching PA, Nabieva N.
    Breast; 2020 Apr 10; 50():11-18. PubMed ID: 31958661
    [Abstract] [Full Text] [Related]

  • 16. Single arm phase II study of oral vitamin B12 for the treatment of musculoskeletal symptoms associated with aromatase inhibitors in women with early stage breast cancer.
    Campbell A, Heydarian R, Ochoa C, Dwivedi AK, Nahleh ZA.
    Breast J; 2018 May 10; 24(3):260-268. PubMed ID: 29442401
    [Abstract] [Full Text] [Related]

  • 17. Omega-3 Fatty Acids for Aromatase Inhibitor-Induced Musculoskeletal Pain: Anything Other Than a Placebo Effect?
    Gianni L, Arcangeli V, Tamburini E, Tassinari D.
    J Clin Oncol; 2015 Dec 20; 33(36):4311-2. PubMed ID: 26392100
    [No Abstract] [Full Text] [Related]

  • 18. Defining the aromatase inhibitor musculoskeletal syndrome: a prospective study.
    Singer O, Cigler T, Moore AB, Levine AB, Hentel K, Belfi L, Do HT, Mandl LA.
    Arthritis Care Res (Hoboken); 2012 Dec 20; 64(12):1910-8. PubMed ID: 22730307
    [Abstract] [Full Text] [Related]

  • 19. Arthralgia induced by endocrine treatment for breast cancer: A prospective study of serum levels of insulin like growth factor-I, its binding protein and oestrogens.
    Lintermans A, Vanderschueren D, Verhaeghe J, Van Asten K, Jans I, Van Herck E, Laenen A, Paridaens R, Billen J, Pauwels S, Vermeersch P, Wildiers H, Christiaens MR, Neven P.
    Eur J Cancer; 2014 Nov 20; 50(17):2925-31. PubMed ID: 25304297
    [Abstract] [Full Text] [Related]

  • 20. Vitamin D and aromatase inhibitor-induced musculoskeletal symptoms (AIMSS): a phase II, double-blind, placebo-controlled, randomized trial.
    Rastelli AL, Taylor ME, Gao F, Armamento-Villareal R, Jamalabadi-Majidi S, Napoli N, Ellis MJ.
    Breast Cancer Res Treat; 2011 Aug 20; 129(1):107-16. PubMed ID: 21691817
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 24.